Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

NCT06273943 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

322

Enrollment

OTHER_GOV

Sponsor class

Conditions

Prevention

Interventions

DRUG: Cabotegravir Tablets, for oral use.
DRUG: Cabotegravir Extended-Release Injectable Suspension, for intramuscular use.
DRUG: Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use
PROCEDURE: Rectal Biopsies

Sponsor

ANRS, Emerging Infectious Diseases